A News Report out of Dublin, Ireland this morning supports our own findings about glycomics and cell damage repair and neural degeneration and repair. A new book is touted as the first book linking glycomics and nerve cell damage repair. The title of the book is "Neural Degeneration and Repair: Gene Expression Profiling, Proteomics and Systems Biology". The book is selling for $113 EU which is about $175 US. Well, it is not quite the first book to link glycomics to neurodegenerative repair. Read more about Expand Your Mind - Improve Your Brain by clicking on the cover of my book.

Analysis of Nerve Cell Damage and Repair using Genomics, Transcriptomics, Proteomics, Glycomics and Systems Biology

DUBLIN, Ireland--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/reports/c91485) has announced the addition of "Neural Degeneration and Repair: Gene Expression Profiling, Proteomics and Systems Biology" to their offering.

With contributions from leading scientists around the world, this is the first book focussing on the analysis of nerve cell damage and repair using genomics, transcriptomics, proteomics, glycomics and systems biology in order to develop novel therapeutic and diagnostic approaches for neural diseases.

Following an introduction into the microarray technology in translational neuroscience, the book goes on to look at the use of '-omics' technologies to analyse molecular changes in traumatic injury, neuron degeneration and regeneration, oxidative stress response, neuropathic pain manifestation, and more. The work covers central nervous system as well as peripheral nervous system pathologies. This novel approach makes the book an indispensable companion for neurobiologists, neurologists, cell and molecular biologists, geneticists, and analytical chemists.

Key Discussions:

- INTRODUCTION

- REACTIONS OF PERIPHERAL NERVE TO TRAUMATIC INJURY AND AXON REGENERATION\

- CENTRAL NERVOUS SYSTEM TRAUMA AND NEURODEGENERATION

- GLYCOMIC TECHNOLOGIES APPLIED TO NERVOUS SYSTEM FUNCTION

The Author is Hans Werner Müller who has been Professor of Molecular Neurobiology at Düsseldorf University since 1993. From 2001 onwards he has acted as the founder of the Neuraxo Biotec GmbH company, where he is also Chairman of the board of directors. He has published more than 150 scientific articles in the field of neurobiology and neuroscience and is an active member of many scientific societies including the American Society for Neurosciences, and the German Society for Neuroscience, where he is chairman of the molecular neurobiology section.

For more information visit http://www.researchandmarkets.com/reports/c91485

May 12, 2008